Lymphocyte Activation Gene (LAG)-3 Is Associated With Mucosal Inflammation and Disease Activity in Ulcerative Colitis
Stephanie Slevin(John Radcliffe Hospital), Satish Keshav(John Radcliffe Hospital), Kate D. Lynch(Royal Adelaide Hospital), Daniel JB Marks(Age UK), Paul Klenerman(John Radcliffe Hospital), Karen Leavens(GlaxoSmithKline (United Kingdom)), Lucy C. Garner(University of Oxford), Kevin Page(University of Oxford), Naren Srinivasan(Age UK), Alessandra Geremia(John Radcliffe Hospital), Borgel Greenaway(John Radcliffe Hospital), Katherine Nevin(GlaxoSmithKline (United Kingdom)), Lai Mun Wang(John Radcliffe Hospital), Stephen Hughes(GlaxoSmithKline (United Kingdom)), Simon Travis(University of Oxford), Conor Lahiff(Beth Israel Deaconess Medical Center), Carolina V. Arancibia-Cárcamo, Malcolm Tan(John Radcliffe Hospital), David Krull(GlaxoSmithKline (United States)), Helen Ferry(University of Oxford), Ruth M. Tarzi(Hammersmith Hospital)
Cited by 55
Related Papers
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
|Nature Medicine|2002|1.6k